-Caveat Lector-
http://www.sightings.com/ufo5/chemtr.htm
Chemtrail/Contrail
Mystery Spraying Solved?
Is This What's Going On?
11-3-99
The following data is profoundly interesting and may offer an
answer to the
ongoing mystery of the spraying of American citizens from the air.
The source
has asked to remain anonymous.
Aerosolized Vaccines And Contrails
Jeff,
This company, Maxygen, has been given a 6.7 million dollar grant
from
DARPA for the development of "aerosolized vaccines." Hhhhmmm.
Interestingly, they are also working on an aerosolized
anti-biological agent
consisting of the commonly used protease, "subtilisin." This is an
enzyme
commonly found in laundry detergents. It has been found to be highly
effective in beaking down bacterial cellular walls, causing the
bacteria to
literally explode into a harmless mass. The idea would be to spray
any
affected area or individuals with this enzyme foam and
decontaminate them,
without the need for toxic substances like formaldehyde.
Apparently, it workd
quite effectively. These clues may point towards an explanation of
these
strange contrails we've been witnessing all over the country.
http://www.maxygen.com/webpage_templates/home.php3?page_name=home
_______________
DARPA Research And Development
Jeff,
The Program Manager is a Navy SEAL and MD, with the rank of
Commander, Shaun Jones. Jones is known as "The Man from DARPA." I
think the trail to solving the mystery contrails leads here. Just
my hunch.
http://www.darpa.mil/DSO/rd/Abmt/Pathogen.html
The goal of the Unconventional Pathogen Countermeasures program is
to
develop and demonstrate defensive technologies that afford the
greatest
protection to uniformed warfighters, and the defense personnel who
support
them, during U.S. military operations. While no defense may stop a
determined adversary from unleashing biological weapon, a
sufficiently
robust array of pathogen defenses and countermeasures " deterrents
in their
own right " will reduce the probable damage that would result from
biological
weapons used in a particular operation.
The most sinister offensive biological warfare scenario employs
surprise,
immediate proximity, and rapidly lethal, persistent agents in
overwhelming
quantities. Under these circumstances, real-time sensing, donning
of physical
protection, and conventional nonmedical countermeasures are only
marginally effective. An effective operational defense ideally
requires instantly
available or emplaced countermeasures that can defeat biological
threats as
they enter the body and before they reach and attack target cells
and tissues.
The focus of the Unconventional Pathogen Countermeasures program is
the
development of revolutionary, broad-spectrum, medical
countermeasures
against significantly pathogenic microorganisms and/or their
pathogenic
products. These countermeasures will be versatile enough to
eliminate
biological threats, whether from natural sources or modified through
bioengineering or other manipulation. They will also have the
potential to
provide protection both within the body and at the most common
portals of
entry (e.g., inhalation, ingestion, transcutaneous). Strategies
include but are
not limited to:
* Defeat of a pathogen's ability to enter the body, traverse the
bloodstream or
lymphatics, and enter target tissues.
* Identification of novel pathogen vulnerabilities based on
fundamental,
critical molecular mechanisms of survival or pathogenesis (e.g.,
Type III
secretion, cellular energetics, virulence modulation).
* Construction of unique, robust vehicles for the delivery of
countermeasures
into or within the body.
* Modulation of the advantageous and/or deleterious aspects of the
immune
response to significantly pathogenic microorganisms and/or their
pathogenic
products in the body.
_______________
Decontamination Methods Based On Industrial Enzymes Optimized for
Killing
of Biological Warfare (BW) Spores
http://www.darpa.mil/DSO/rd/UPC/0034.html
Maxygen, Inc. Redwood City, CA
Willem Stemmer, (Principal Investigator) Pascal Longchamp,
Scientific
Project Leader, Maxygen Inc. <mailto:[EMAIL PROTECTED]
[EMAIL PROTECTED] Lori Giver, Scientist, Maxygen Inc. Jon
Ness, Scientist, Maxygen Inc. Mark Welch, Scientist, Maxygen Inc.
Anders
Pedersen, Scientific Project Leader, Novo Nordisk A/S
The goal of the Maxygen/Novo collaborative DARPA project is to
create
decontamination reagents for Biological Warfare (BW) pathogens
using a
powerful new platform technology, DNA shuffling. DNA shuffling is a
revolutionary method for directed evolution. Maxygen uses a
preferred
format, called family shuffling, to create large libraries of
chimaeric genes
encoding industrial enzymes that will be screened for antimicrobial
activity
against spore forming BW pathogens. In this project we integrate
Novo
Nordisk's expertise in industrial enzyme technology and production
with
Maxygen's expertise in DNA shuffling and library screening
technologies.
Pathogenic spore-forming bacteria like Bacillus anthracis,
Clostridium
botulinum, C. difficile, C. perfringens and C. tetani form spores
which survive
in harsh environmental conditions for extended periods of time. The
spore
nucleoid structure is surrounded by protective layers composed of
peptidoglycan and proteins with unusual amino acids content. This
structure
provides unique resistance properties acting as a permeability
barrier to
prevent access to the underlying spore protoplast. Spores are able
to survive
exposure to chlorinated solvents, detergents, mechanical
disruption, extreme
temperatures, UV and ionizing radiation. These organisms can be
bioengineered to maximize pathogenicity and the spores easily
weaponized
and stored. The possible use of spores in BW or terrorist
activities argues for
an enzyme-based, broad spectrum decontamination formulation for
personnel, equipment and environment. Integration of our
technologies and
expertise will result in the development of effective
spore-degrading enzymes
and a novel platform for rapid enzyme development against a wide
variety of
wild-type and recombinant spore-forming BW pathogens.
Last Updated: Oct 20, 1998
_______________
Revealing DARPA Page Loaded With Intriguing References To Advanced
BioWarfare And Related Research Many of which could have
application via
mass spraying and aerosolization.
http://www.darpa.mil/DSO/rd/UPC/NavIndex/index.html (Go to this
page to
access direct links to any of the topics listed below)
Anti-Bacterials Anti-Toxins Anti-Viral Decontamination External
Protection
Immunization Multi-Purpose
Anti-Bacterials Sweden Defence Research Establishment (FOA) Ume�,
Sweden
Common Signatures of Infected Eukaryotic Cells U.S. Harvard Medical
School Boston, MA
To Exploit the Essential Cell Division Protein FtsZ as a
Broad-Spectrum
Anti-Bacterial Target U.S. Ibis Therapeutics Carlsbad, CA
Universal Pathogen Countermeasures U.S. Isis Pharmaceuticals
Carlsbad,
CA <
Drugs to Protect Against Engineered Biological Warfare Bacteria U.S.
SmithKline Beecham Pharmaceuticals Collegeville, PA
Novel Broad Spectrum Antimicrobial Agents - Gene Expression U.S.
Stanford
University Stanford, CA
Novel Targets of Pathogen Vulnerability U.S. Stanford University
School of
Medicine Stanford, CA
Common Targets of Pathogen Vulnerability
Anti-Toxins Israel The Hebrew University of Jerusalem Jerusalem,
Israel
Superantigen Toxin Antagonist and Vaccine U.S. Los Alamos National
Laboratory Los Alamos, NM
Structural Biology of Bacterial Toxins U.S. Rockefeller University
New York,
NY
Rapid Method to Express Biologically Active Proteins on the Surface
of
Gram-Positive Bacteria for Biological and Vaccine Purposes U.S.
Stanford
University Stanford, CA
Creating Cellular Resistance to Toxins in Mammals
Anti-Viral U.S. enVision Cherry Hill, NJ
Developmental Proteins to Prevent Human Injury from Pathogens U.S.
Genelabs Technologies, Inc. Redwood City, CA
Stockpiling Drug Subunits for Rapid Response to Biological Warfare
U.S.
Hughes Institute Saint Paul, MN
Pokeweed Antiviral Protein as a Universal Virus Neutralizer U.S.
The Scripps
Research Institute La Jolla, CA
Invasive (Intra-cellular) Antibodies U.S. Stanford University
School of
Medicine Stanford, CA
A Common Target for Positive-Strand RNA Viruses U.S. University of
Texas
Medical Branch at Galveston Galveston, TX
Structure-based Design of Acute Countermeasures to Viruses U.S.
University
of Wisconsin Madison, WI
Non-Peptide Antiviral Agents that Interdict Host Cell Transport
U.S. Xavos
San Francisco, CA
Intraneuronal Drug Delivery
Decontamination U.S. Maxygen, Inc. Redwood City, CA
Decontamination Methods Based on Industrial Enzymes Optimized for
Killing
of Biological Warfare (BW) Spores U.S. University of Michigan Ann
Arbor, MI
Molecular Decoys to Soak up Pathogens
External Protection U.S. Harvard University Cambridge, MA
Polyvalent Inhibitors of Adhesion of Microorganisms, Viruses, and
Toxins
U.S. Molecular Geodesics Inc. Boston, MA
Biomimetic Materials for Pathogen Neutralization U.S. Northrop
Grumman
Corporation Bethpage, NY
Personal Environmental Protection System
Immunization U.S. Boyce Thompson Institute for Plant Research, Inc.
Ithaca,
NY
High Level Expression of Vaccine Antigens and Epithelial Transport
Molecules In Transgenic Plant Cells and Organs U.S. Harvard
University
Boston, MA
Novel Bacteriophage Therapies for Vibrio cholerae Infection U.S.
Massachusetts General Hospital /Harvard Medical School Boston, MA
Super Immune Cells U.S. Maxygen, Inc. Redwood City, CA
Improved Vaccines by DNA Shuffling of Pathogen Antigens U.S. OSIRIS
Therapeutics, Inc. Baltimore, MD
Sequential Auto Vaccination by Stem Cells U.S. University of
Connecticut
School of Medicine Farmington, CT
Heat Shock Protein-Peptide Complexes as Anti-Viral Agents U.S.
University
of Texas-Southwestern Medical Center Dallas, TX
Instant Immunization
Multi-Purpose U.S. Abitis Pharmaceuticals LLC Dallas, TX
Neuroimmunomodulatory alpha-MSH peptides U.S. Alnis, LLC San
Leandro,
CA
Novel Pathogen Countermeasures via Molecular and Nano-Surface
Recognition U.S. Boston University Boston, MA
Red Blood Cell Pathogen Defense - Destruction U.S. ChemoCentryx San
Carlos, CA
Development of Novel Dendritic Cell-Active Chemokine Modalities and
Advanced Cell Detection Technologies for Intensified Vaccination and
Accelerated Immunotherapy U.S. GeneSoft, Inc. South San Francisco,
CA
Genetic Countermeasures: Regulation of Pathogen Gene Expression by
DNA-Binding Polyamides U.S. Inotek Corporation Beverly, MA
Mercaptoethylguanidine: A Revolutionary Generic Immunomodulatory
Countermeasure for Biological Warfare Defense U.S. Maxygen, Inc.
Redwood City, CA
Genetic Vaccine Vectors Evolved for Optimal Immunization with
Pathogen
Antigens U.S. Rush Medical Center Chicago, IL
Ionic Channels U.S. University of Michigan Ann Arbor, MI
Intracellular Sensors of Virulence U.S. University of Iowa Iowa
City, IA
Activation of Innate Immunity by CpG DNA for Broad Spectrum
Protection
Against Pathogens U.S. University of Texas-Southwestern Medical
Center
Dallas, TX
Paraimmunity, Super Vaccines, and Chemical Genomics U.S. University
of
Virginia School of Medicine Charlottesville, VA
Red Blood Cell Pathogen Defense - Decoy
------------------------------------------------------------------------
Steve Wingate
California Director
SKYWATCH INTERNATIONAL
Anomalous Images and UFO Files
http://www.anomalous-images.com
DECLARATION & DISCLAIMER
==========
CTRL is a discussion and informational exchange list. Proselyzting propagandic
screeds are not allowed. Substance�not soapboxing! These are sordid matters
and 'conspiracy theory', with its many half-truths, misdirections and outright
frauds is used politically by different groups with major and minor effects
spread throughout the spectrum of time and thought. That being said, CTRL
gives no endorsement to the validity of posts, and always suggests to readers;
be wary of what you read. CTRL gives no credeence to Holocaust denial and
nazi's need not apply.
Let us please be civil and as always, Caveat Lector.
========================================================================
Archives Available at:
http://home.ease.lsoft.com/archives/CTRL.html
http:[EMAIL PROTECTED]/
========================================================================
To subscribe to Conspiracy Theory Research List[CTRL] send email:
SUBSCRIBE CTRL [to:] [EMAIL PROTECTED]
To UNsubscribe to Conspiracy Theory Research List[CTRL] send email:
SIGNOFF CTRL [to:] [EMAIL PROTECTED]
Om
